NCT06613919View on ClinicalTrials.gov

Six-months Versus Nine-months ATT for Ocular TB

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Tuberculosis (TB)UveitisRetinal VasculitisChoroiditis
Interventions
DRUG

Anti-Tuberculosis Treatment

Standard, weight adjusted anti-TB therapy for six months

DRUG

Anti-Tuberculosis Treatment

Standard, weight-adjusted anti-TB therapy for nine months

Trial Locations (3)

751034

LV Prasad Eye Institute, Bhubaneswar

Unknown

University of Medicine Magway, EENT Hospital, Nay Pyi Taw

Ramathibodi Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

L.V. Prasad Eye Institute

OTHER

NCT06613919 - Six-months Versus Nine-months ATT for Ocular TB | Biotech Hunter | Biotech Hunter